Lobbyist
14 clients across 1 state
2 gained, 1 lost in 2025.
| Client | Change | State | Period |
|---|---|---|---|
| Solventum | Gained | Texas | 2025 |
| Medify Air | Gained | Texas | 2025 |
| 3M CORPORATION | Lost | Texas | 2025 |
| Client | State | Since | Until |
|---|---|---|---|
| 3M CORPORATION | Texas | 2018-01-07 | 2024-12-31 |
| Acadia Pharmaceuticals, Inc. | Texas | 2023-01-01 | 2026-12-31 |
| Crispr Therapeutics | Texas | 2019-10-30 | 2021-12-31 |
| Cystic Fibrosis Foundation | Texas | 2018-01-07 | 2026-12-31 |
| Deloitte Consulting, LLP | Texas | 2018-01-07 | 2018-12-31 |
| Dexcom, Inc. | Texas | 2019-08-19 | 2026-12-31 |
| Medify Air | Texas | 2025-01-02 | 2025-12-31 |
| Newlight Healthcare LLC | Texas | 2020-01-02 | 2026-12-31 |
| Novo Nordisk Inc. | Texas | 2018-01-07 | 2021-12-31 |
| Roche Diagnostics Corporation | Texas | 2018-01-07 | 2026-12-31 |
| Solventum | Texas | 2025-01-02 | 2026-12-31 |
| Texas Pharmacy Association | Texas | 2021-01-01 | 2022-12-31 |
| Vertex Pharmaceuticals Inc. | Texas | 2018-01-07 | 2026-12-31 |
| VIMO, INC. | Texas | 2023-01-30 | 2025-12-31 |
No compensation figure appears here because the states involved do not require lobbyists to disclose what they are paid.